Exploring the Resurgence of the Preservation Rhinoplasty: A Systematic Literature Review
Aesthetic Plastic Surgery · 2023-08 · 47 (4) · 1488-1493
DOI: 10.1007/s00266-023-03345-8 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Aesthetic Plastic Surgery, online erschienen am 02.05.2023. Verfasst von Michael W Wells und 5 weiteren Autor:innen. Beteiligte Einrichtung: Case Western Reserve University School of Medicine, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Rhinoplasty. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: The underlying principles of preservation rhinoplasty (PR) center around maintaining the soft tissue envelope, dorsum, and alar cartilage through surgical manipulations and tip suture techniques. In particular, the let-down (LD) and push-down (PD) techniques have been described, although reports of indications and outcomes in the literature are sparse. METHODS: A systematic review of the literature was performed using search terms "preservation" OR "let down" OR "push down" AND "rhinoplasty" on PubMed, Cochrane, SCOPUS, and EMBASE databases. Patient demographic information, operative details, and surgical outcomes were recorded. Sub-cohorts for patients who underwent LD and PD techniques were analyzed utilizing Fischer's exact test for categorical variables and Student's t test for continuous variables. RESULTS: Overall, there were 5967 PR patients in 30 studies in the final analysis, with 307 patients in the PD cohort and 529 patients in the LD cohort. The Rhinoplasty Outcome Evaluation Questionnaire showed a significant increase of patient satisfaction after PR compared to before PR (62.13 vs 91.14; p < 0.001). There was a significantly lower rate of residual dorsal hump or recurrence of 1.3% (n = 4) in the PD when compared to 4.6% (n = 23) in LD cohorts (p = 0.02). The revision rate of PD (0%, n = 0) was also significantly lower than that of LD (5.0%, n = 25) (p < 0.001). CONCLUSION: Based on these published articles, it seems that preservation rhinoplasty is safe and efficacious procedure with improved dorsal aesthetic lines, reduced dorsal contour irregularities, and claimed excellent patient satisfaction. In particular, the PD technique has fewer reported complications and revisions than LD approach, although PD is often indicated in patients with smaller dorsal humps. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Case Western Reserve University School of Medicine, Cleveland, OH, USA.
- Department of Plastic and Reconstructive Surgery, Cleveland Clinic Foundation, Cleveland, OH, USA.
- Case Western Reserve University School of Medicine, Cleveland, OH, USA. bguyuron@guyuron.com.
- Zeeba Clinic, 29017 Cedar Road, Lyndhurst, Cleveland, OH, 44124, USA. bguyuron@guyuron.com.
ORCID-Profile: Michael W Wells
Zitieren
APA
Wells, M. W., DeLeonibus, A., Barzallo, D., Chang, I. A., Swanson, M., & Guyuron, B. (2023). Exploring the Resurgence of the Preservation Rhinoplasty: A Systematic Literature Review. Aesthetic Plastic Surgery, 47(4), 1488-1493. https://doi.org/10.1007/s00266-023-03345-8
Vancouver
Wells MW, DeLeonibus A, Barzallo D, Chang IA, Swanson M, Guyuron B. Exploring the Resurgence of the Preservation Rhinoplasty: A Systematic Literature Review. Aesthetic Plastic Surgery. 2023;47(4):1488-1493. doi:10.1007/s00266-023-03345-8
BibTeX
@article{Wells2023,
author = {Wells, Michael W and DeLeonibus, Anthony and Barzallo, Devin and Chang, Irene A and Swanson, Marco and Guyuron, Bahman},
title = {Exploring the Resurgence of the Preservation Rhinoplasty: A Systematic Literature Review},
journal = {Aesthetic Plastic Surgery},
year = {2023},
volume = {47},
number = {4},
pages = {1488--1493},
doi = {10.1007/s00266-023-03345-8}
}
EUVIMED